Early-stage trial data on AstraZeneca COVID-19 vaccine due July 20 - Lancet

  • 📰 Reuters
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

The Lancet medical journal said on Wednesday it will publish keenly-awaited phase 1 clinical trial data on a potential COVID-19 vaccine being developed by Astrazeneca and Oxford University on Monday.

“We expect this paper, which is undergoing final editing and preparation, to be published on Monday, July 20, for immediate release,” a spokeswoman for the journal said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

should I buy or sell ?

Oh shit. AstraZeneca will price-gouge everyone!

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna expects to start late-stage COVID-19 vaccine trial on July 27Moderna Inc said on Tuesday it plans to start a late stage clinical trial for its COVID-19 vaccine candidate on or around July 27, according to its listing for the phase 3 study at clinicaltrials.gov. At this point in the constant pump train, would they even tell us about severe side effects? When Trump said by the end of the year everybody laughed at him stop hating and start hoping Why does it look like Tesco own brand?
Source: Reuters - 🏆 2. / 97 Read more »

Potential COVID-19 vaccine shows promise in early trial'It is good news that it's not bad news,' infectious disease expert Dr. Michael Osterholm says about promising results from Moderna's first COVID-19 vaccine trial. 'But remember, we're in the first 100 yards of a marathon.'
Source: MSNBC - 🏆 469. / 51 Read more »